Key opportunities in the Bronchiectasis clinical trials market include leveraging comprehensive data on trial distribution by region, identifying cost-effective trial locations, assessing trial ...

Mediated Chemotherapeutic Delivery and Reinforces its Potential to Provide Individualized, Optimized Drug-DeliveryMOUNTAIN ...

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Roivant Sciences (ROIV) upgraded to Buy on strong Phase 2 BEACON data for brepocitinib; see pipeline upside, risks, and why ...

The report highlights strategic insights into global Crohn's Disease clinical trials, emphasizing opportunities for investment and cost-efficient trial locations. It aids in formulating business ...

Avalo Therapeutics completed Phase 2 enrollment for AVTX-009, with mid-2026 data ahead. Cantor sees major upside if results ...

Key market opportunities in cSCC clinical trials include identifying strategic investment areas, leveraging prominent trial locations to cut costs, and understanding trial success rates. The report's ...

REGENXBIO shares sink after the FDA places a clinical hold on two gene therapy trials following a safety concern tied to ...

Biotech stocks are in focus as analysts track upcoming clinical data and regulatory decisions in autoimmune and rare disease ...

Pfizer announces the first data from its Metsera-acquired pipeline just ahead of its earnings call, where analysts pressed ...

A long-acting shot Pfizer got through a buyout of Metsera appeared “slightly inferior” to Lilly’s market-leading Zepbound in ...

“We’re at a transformative moment in the biomedical sciences,” says James Lu, an AI scientist at the Agency for Science, Technology and Research Bioinformatics Institute (A*STAR BII) in Singapore.